El-Hashemite, Nisreen <br/><br/>
Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma.  [electronic resource] 

 -  Lancet (London, England)  Apr 2003 
 - 1348-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0140-6736 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(03)13044-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiomyolipoma--genetics<br/>Animals<br/>Antibiotics, Antineoplastic--pharmacology<br/>Cell Division--drug effects<br/>Germ-Line Mutation--genetics<br/>Humans<br/>Immunoenzyme Techniques<br/>Kidney--pathology<br/>Kidney Neoplasms--genetics<br/>Mice<br/>Phosphorylation--drug effects<br/>Protein Kinase Inhibitors<br/>Protein Kinases--genetics<br/>Proteins--genetics<br/>Repressor Proteins--genetics<br/>Ribosomal Protein S6 Kinases, 70-kDa--genetics<br/>Signal Transduction--drug effects<br/>Sirolimus--pharmacology<br/>TOR Serine-Threonine Kinases<br/>Tuberous Sclerosis--genetics<br/>Tuberous Sclerosis Complex 1 Protein<br/>Tuberous Sclerosis Complex 2 Protein<br/>Tumor Suppressor Proteins